Amersin Appoints Director
November 17, 2005 12:21 ET
|
Amersin Life Sciences Corp.
NEW YORK, Nov. 17, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) (Frankfurt:HUQ) is pleased to announce the immediate appointment of Mr. Rob Gillingham to its Board of...
Amersin Enters Into Termination Agreement With Chinese Joint Venture Partner
October 20, 2005 16:30 ET
|
Amersin Life Sciences Corp.
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLSE) announced today that it has reached a termination agreement and will be disposing of its interest in the Hubei...
Amersin Notifies Chinese Joint Venture That it Will Not be Providing Additional Funds
September 15, 2005 17:56 ET
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 15, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) Chief Executive Officer, H.Y. (Reid) Li, announced that the company notified the minority partners in its Hubei...
Amersin Announces Delay in Filing Annual Report Due to Auditor's Workload
May 18, 2005 09:30 ET
|
Amersin Life Sciences Corp.
NEW YORK, May 18, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that delays resulting from workload in the office of its auditors, Moen and Company, will result in...
Amersin Subsidiary Makes Application to State Food and Drug Administration For New Antiviral Drug License
May 12, 2005 10:38 ET
|
Amersin Life Sciences Corp.
NEW YORK, May 12, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. (Hubei Benda), has applied to the...
Amersin Subsidiary Receives 30 Million RMB Contract
April 06, 2005 09:00 ET
|
Amersin Life Sciences Corp.
NEW YORK, April 6, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million...
Amersin Life Science Announces Appointment of Director
March 01, 2005 14:10 ET
|
Amersin Life Sciences Corp.
NEW YORK, March 1, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS), is pleased to announce the appointment Mr. (Harry) Zhihao Jin to its board of directors.
Mr. Harry Jin served...
Amersin Announces 30% Increase in Ribavirin Production to Meet Market Demand Following Recent Avian Flu Outbreaks in Asia
January 31, 2005 06:00 ET
|
Amersin Life Sciences Corp.
NEW YORK, Jan. 31, 2005 (PRIMEZONE) -- Amersin Life Sciences Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBPharma), will increase...
Hubei Pharmaceutical Group Reports Second Quarter Operational Profit of $681,666
September 23, 2004 09:00 ET
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 23, 2004 (PRIMEZONE) --
---------------------------------------------------------------------
Operational Results Second Quarter Six Months
at a Glance ...
Hubei Pharmaceutical Group to Sell Joint Venture Interest
September 14, 2004 13:09 ET
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 14, 2004 (PRIMEZONE) -- Hubei Pharmaceutical Group (OTCBB:HBEI) filed notice with the SEC today that it will sell its joint venture interest in Hubei Pharmaceutical Co. Ltd....